Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sproutly Canada Inc. C.SPR

Alternate Symbol(s):  SRUTF

Sproutly Canada, Inc. is a Canada-based company that is a supplier of all-natural water-soluble and oil ingredients for cannabis products for the beverage and consumables market. The Company intends to identify and evaluate potential business opportunities in the medicinal and recreational cannabis industry. The Company's Health Canada Licensed Facility is located in the greater Toronto area... see more

CSE:SPR - Post Discussion

Sproutly Canada Inc. > 104 million reasons to keep $proutly going....
View:
Post by Blizzy420 on Sep 02, 2020 5:49pm

104 million reasons to keep $proutly going....

Let's start with how much $proutly paid IBS for the technology license.  
IBS got...
$4,525,000 & 36,857,676 shares w/ Additional 14,743,070 shares upon milestones

BNO Holding Inc (whoever that is) got...
$4,975,000 & 22,114,605 shares upon an earn out

Since IBS has loaned $1,855,000 that only leaves him with $2,670,000 for his life's work.

Doesn't sound too good does it?  

Now let's look at IBS' stake in $proutly
Original - 36,857,676 shares
Earnout - 14,743,070 shares
$1 mil raise - 14,285,714 shares + warrants/options
$855k raise - 12,214,286 shares + warrants/options
Total - 104,600,746 shares all in or 30% of all outstanding shares

The downturn and dilution of this stock has not cost IBS any longterm potential gain.   They have put forth an additional $1,855,000 of their own money and slightly increased their ownership from 29.74% to 30.03% over this period.    If this stock can reach old highs above $1 Dr Sen and Mr Marcelino would stand to have over $100 million in stock and still own the rights to the US license for APP.   

Doesn't $100+ million sound like a lot more desired outcome for IBS than having to walk away from $proutly with your tail between your legs paying pennies on the dollar for a technology assocaited with failure.  

I will go over some debt stuff later when I have a chance.
Comment by ScotiaOne on Sep 02, 2020 6:17pm
I would feel a lot more confident with your theory Blizz if we knew how the Oct. debt is going to be handled but i still like it.  
Comment by Hailmerry on Sep 02, 2020 6:42pm
Thanks Again Blizzy.
Comment by Zookie on Sep 02, 2020 7:52pm
thanks, Blizzy.  Great perspective - as usual.  
Comment by SUMKNDV1DERFL on Sep 02, 2020 8:52pm
Great review, well summarized.  As other longs, I am anticipating Sen’s plan for the debt load. 
Comment by Blizzy420 on Sep 02, 2020 11:34pm
Thanks for the compliments all.   Like many of you I believe in this technology and I believe in my assessment of its potential along with my judgement on Arup Sen as an honest individual with a desire to produce a product that helps society while making him rich in the process. Rightfully so there are lots of questions about the debt will be addressed by October.    I do ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities